Bengaluru, July 16 -- The shares of this leading pharmaceutical company are in focus after receiving further approval for its injection to treat cancer and other illnesses. In this article, we will dive more into the details.

With a market capitalisation of Rs 795 crore, the shares of Sakar Healthcare Ltd are currently trading at Rs 362 per share, down by 5 percent from its 52-week high of Rs 380.80 per share. Over the past five years, the stock has delivered a robust return of 556 percent.

On Wednesday, the company, through a stock exchange filing, announced that the company has received the receipt of two more marketing authorisations (MA) of Oncology Injection for the European Union, taking the total count to four MAs.

The names of ...